Press release
Peptide-Drug Conjugates Market Growth and Future Clinical Trial Analysis with Revenue Forecast Till 2034
Peptide-Drug Conjugates (PDCs) Market
According to the latest research by InsightAce Analytic, the global peptide-drug conjugates (PDCs) market is expected to record a promising CAGR of 18.8% during the period of 2025-2034. By region, North America dominates the global peptide-drug conjugates (PDCs) market with the largest share.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1351
Peptide-drug conjugates (PDCs) are targeted therapeutic agents designed to specifically target tumor cells and release cytotoxic agents. The growing investments by key industry players to develop promising therapies are expected to drive the market's growth throughout the forecast period. The emergence of PDCs as a treatment option for various types of cancers is anticipated to create significant clinical opportunities. PDCs utilize a peptide chain consisting of approximately ten amino acids to target tumor cells. Their smaller molecular weight compared to antibody-drug conjugates (ADCs) enables faster accumulation at tumor sites, while the short half-life of the drug molecules in the bloodstream aids in reducing toxic side effects by minimizing off-target effects.
As a novel targeted therapy, PDCs offer enhanced tumor penetrance and selectivity. The development of PDCs is a promising area of research, with two PDCs already available in the market. With proper design and focused application, PDCs are expected to have a considerable impact on the targeted therapy market by delivering safer and more effective treatments. The increasing number of pharmaceutical innovations in drug development is anticipated to further boost the growth of the PDCs market. Additionally, the robust clinical pipeline for PDCs is likely to result in rapid approvals for cancer treatments, contributing to market expansion in the coming years.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
However, several limitations hinder the growth of the PDCs market. The high cost of treatment, complex procedures, and a lack of stringent government regulations may impede market development. Furthermore, the COVID-19 pandemic negatively impacted the market due to lockdowns and disruptions to clinical trials. The slow approval process for pipeline products, coupled with a limited number of PDC-related approvals from the FDA in recent years, is also expected to affect the market's growth during the forecast period.
Regionally, North America, followed by Europe, is projected to dominate the PDCs market due to the high prevalence of cancer, rapid adoption of advanced technologies, growing awareness of therapeutic drugs, and increasing government investments in research and development. The Asia-Pacific region is expected to experience significant growth in the future, driven by advancements in modern technologies and a rising prevalence of cancer in the region.
The key players involved in peptide-drug conjugates (PDCs) industry are Novartis AG, AstraZeneca, Bicycle Therapeutics, Cybrexa Therapeutics, Esperance Pharmaceuticals, Oncopeptides AB, Pepgen Corporation, Soricimed Biopharma, Theratechnologies, Pfizer Inc, Validus Pharmaceuticals LLC, Antisense Therapeutics, Midatech Pharma PLC, Ipsen Pharma, Chiasma, Inc., Peptron, Inc., CRINETICS PHARMACEUTICALS, Dauntless Pharmaceuticals, Camurus AB, Teva Pharmaceuticals Inc., Pharmaspur, Aspire Pharmaceuticals, Ionis Pharmaceuticals Inc, Midatech Pharma Plc, and Other Prominent Players. This field's leading players use strategies like novel therapy innovations, partnerships, collaborations, mergers, and agreements.
Key developments in the market
• In Dec 2021, A strategic partnership agreement was signed between Coherent Biopharma and WuXi STA. In order to speed up the development of its current and future drug candidates (small molecules, peptides, oligonucleotides, complex chemical conjugates, etc.), from API to drug product, the company will offer Coherent Biopharma integrated CMC services.
• In Oct 2021, Oncopeptides AB announced the withdrawal of Pepaxto® (INN melphalan flufenamide) from the US market. Oncopeptides will collaborate with the FDA to keep the drug available for patients who are currently receiving Pepaxto treatment.
• In July 2020, AstraZeneca and Daiichi Sankyo formed a new $6 billion global ADC alliance to co-develop and commercialise DS-1062, a TROP2 directed DXd antibody-drug conjugate in Phase I for non-small cell lung cancer and breast cancer. The businesses will share development and commercialization costs as well as profits from DS-1062 worldwide, except for Japan.
• In June 2019, Novartis AG and PeptiDream Inc. signed a new Peptide Drug Conjugate "PDC" collaboration agreement to initiate macrocyclic peptide discovery, which will be used to address therapeutic and diagnostic applications.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1351
Market Segments
Global peptide-drug Conjugates (PDCs) Market, by Product, 2022-2030 (Value US$ Mn)
• Lutetium Lu 177 dotatate
• Melflufen
• ANG1005
• BT1718
• CBX-12
• Other Pipeline Products
Global peptide-drug Conjugates (PDCs) Market, by Indication, 2022-2030 (Value US$ Mn)
• Relapsed/Refractory Multiple Myeloma
• Neuroendocrine Tumors (NETs)
• Gastric Cancers
• Acromegaly
• Ophthalmology
• Other Cancer Indication
Global peptide-drug Conjugates (PDCs) Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Peptide-drug Conjugates (PDCs) Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-peptidedrug-conjugates-pdcs-market/1351
Why should buy this report:
• To receive a comprehensive analysis of the prospects for global peptide-drug conjugates (PDCs) products
• To receive industry overview and future clinical trial/pipeline trends of global peptide-drug conjugates (PDCs) market
• To analyse the peptide-drug conjugates (PDCs) market drivers and challenges
• To get information on peptide-drug conjugates (PDCs) market size value (US$ Mn) forecast till 2030
• To get information on major Investments, Mergers & Acquisition in global peptide-drug conjugates (PDCs) market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide-Drug Conjugates Market Growth and Future Clinical Trial Analysis with Revenue Forecast Till 2034 here
News-ID: 4015586 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Minimally Invasive Fascial Closure Device Market Exclusive Report on the Latest …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Minimally Invasive Fascial Closure Device Market - (by Type (Winged Structure, Shield Structure) by Application (Hospital, Clinic)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Minimally Invasive Fascial Closure Device Market is valued at US$ 331.2 Mn in 2023, and it is expected to reach…
Mineral Fertilizers Market Report Latest Trends and Future Opportunities Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Mineral Fertilizers Market- (By Nutrient type (Nitrogen, Phosphate, Potash), By Crop Type (Oilseeds, Cereals, Fruits, Vegetables, Others), By Application Method (Foliar Spray, Fertigation, Drop Spreading/Placement, Broadcasting)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Mineral Fertilizers Market Size is valued at USD 114.7 Mn in…
Microbiome Manufacturing Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microbiome Manufacturing Market - (by Type of Product Manufactured (API and FDF), Type of Formulation (Solid, Liquid and Others), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large)), Trends, Industry Competition Analysis, Revenue…
Microbiology Reagents Market Deep Research Report with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Microbiology Reagents Market - (By Type (Testing Reagent, Staining Reagent, Culture Medium, Antibiotic Solution, Others), By Type of Reagent (Silica gel, Agar Powder, Gelatin Powder and Others), By Product Type (Pathogen Specific Kits, General Kits), By End User Industry (Healthcare, Pharmaceuticals, Food & Beverage, Agriculture, Cosmetics, Clinical Microbiology, Academia, Others)), Trends, Industry Competition Analysis, Revenue…
More Releases for PDC
PDC Drill Bits Market Forecast 2025-2034 | Growth & Trends
The new report by Expert Market Research (EMR), titled 'Global PDC Drill Bits Market Report and Forecast 2025-2034', offers a comprehensive analysis of the global PDC drill bits market. The report evaluates the market based on segments such as type, cutter size, number of blades, application, and major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. It also studies the latest market trends…
PDC Drill Bits Market May Set New Growth Story
Global PDC Drill Bits Market Report from DiMarket highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved…
PDC Drill Bits Market Projections and Strategic Insights 2024-2030
𝐏𝐃𝐂 𝐃𝐫𝐢𝐥𝐥 𝐁𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 :
Synthetic diamond cutters are used in the production of polycrystalline diamond compact (PDC) drill bits. The drilling business was revolutionised by the widespread use of PDC drill bits due to their high penetration rate and wide range of applications. PDC bit utilisation necessitates the use of special PDC cutter technology in order to maximise drilling performance across…
PDC Market Sluggish Growth Rate Foreseen by 2023-2029
PDC Market Value growing at a CAGR of 6.75% during 2023-2029. Our report on the Polycrystalline Diamond Compact (PDC) market is an invaluable asset for professionals looking to make informed decisions about the future of the industry.
Important changes in the business allow key players to attain larger profits. This PDCMarket study report is the best way to make changes with the help of entire market condition and metrics provided here.…
Global PDC Drill Bits Market Research Report 2023-2029
Polycrystalline diamond compact (PDC) drill bits are primarily used in the drilling tools for the oil and gas industry. The fixed-head bits used in the PDC cutters for drilling are called PDC drill bits.
PDC Drill Bits report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PDC Drill Bits market is projected to reach US$ 3758 million in 2029, increasing from US$ 2940.2…
Global PDC Drill Bits Market Analysis by 2020-2025
Scope of the Report:
The global PDC Drill Bits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
PDC Drill Bits market is split by Type and by Application. For the period 2015-2025, the growth…
